Where research becomes impact
:brightness(0))
Leading visionary biomaterial innovation
Science inspired by nature, designed to empower people to redefine how they age.
At Nordberg Medical, Swedish research excellence meets practical innovation in biomaterials and implantable medical devices.
Our Research & Development framework is built on a five-tier model of scientific evidence — from fundamental hypotheses to clinical validation and real-world outcomes. This lifecycle approach ensures every innovation we pursue is grounded in data, purposefully translated into practice, and aligned with the evolving needs of patients and practitioners
At the core of our approach stands a multidisciplinary team of scientists and clinicians, working closely together in advancing biomaterial research that integrates intelligently with the human tissue and supports the next generation of regenerative therapies. As pioneers at the forefront of regenerative medicine, we collaborate closely with Sweden’s leading academic institutions, including Karolinska Institute. This commitment enables us to accelerate meaningful progress in the global field of aesthetic and regenerative biotechnology.
Translating biotech innovation into clinical impact across high-need medical domains.
Through clinical studies and biomaterial innovation, we advance the science of skin quality and age-related tissue regeneration.
Our research focuses on collagen regeneration as a foundational mechanism for restoring elasticity, firmness, and structure — enabling long-lasting skin tightening treatments without compromising natural expression. This approach places Nordberg Medical at the forefront of regenerative medicine aesthetic innovation, where biotechnology meets beauty with purpose.
JULÄINE™, our flagship collagen biostimulator, is the result of years of research into the role of poly-L-lactic acid microspheres in skin regeneration. Developed in Sweden and powered by our proprietary LASYNPRO™ technology, JULÄINE™ activates the skin’s natural collagen production, promoting skin tightening, improving skin quality, and delivering gradual, measurable, and biocompatible outcomes. Ongoing and planned clinical studies continue to expand the evidence base for JULÄINE™, reinforcing our belief in the great potential of regenerative aesthetics.
Together with our partners, we turn biomedical science into real-world solutions.
Nordberg Medical collaborates with leading institutions such as Karolinska Institute and the Research Institutes of Sweden to drive scientific progress in biotechnology science. These collaborations ensure that our innovations are grounded in evidence, peer-reviewed expertise, and meaningful clinical application.
At Nordberg Medical, you’ll work at the intersection of biomaterial innovation, clinical research and patient-centered progress — with impact that goes beyond the lab.